Back to top

Viridian Therapeutics announces FDA approval, launch of Lumvoa

Viridian Therapeutics (VRDN) announced that the U.S. FDA has approved Lumvoa for the treatment of thyroid eye disease. TED is a rare, debilitating ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Viridian Therapeutics, Inc. (VRDN)